Opthea Ownership
OPT Stock | USD 3.18 0.11 3.58% |
Opthea |
Opthea Stock Ownership Analysis
The company recorded a loss per share of 2.25. Opthea had not issued any dividends in recent years. The entity had 5:8 split on the 15th of October 2020. Opthea Limited, a clinical stage biopharmaceutical company, develops and commercializes therapies primarily for eye disease in Australia. Opthea Limited was incorporated in 1984 and is based in South Yarra, Australia. Opthea operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. To find out more about Opthea contact MAICD MAICD at 61 3 9826 0399 or learn more at https://opthea.com.Besides selling stocks to institutional investors, Opthea also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Opthea's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Opthea's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Opthea Quarterly Liabilities And Stockholders Equity |
|
Opthea Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Opthea is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Opthea backward and forwards among themselves. Opthea's institutional investor refers to the entity that pools money to purchase Opthea's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares | Frazier Financial Advisors, Llc | 2024-09-30 | 0.0 | Royal Bank Of Canada | 2024-09-30 | 0.0 | Jane Street Group Llc | 2024-12-31 | 0.0 | Bank Of Montreal | 2024-09-30 | 0.0 | Bmo Capital Markets Corp. | 2024-09-30 | 0.0 | Stratos Wealth Partners, Ltd | 2024-12-31 | 0.0 | Victory Capital Management Inc. | 2024-09-30 | 0.0 | Teacher Retirement System Of Texas | 2024-09-30 | 0.0 | Vgi Partners Pty Ltd | 2024-12-31 | 2.9 M | Baker Bros Advisors Lp | 2024-12-31 | 2.2 M | Hsbc Holdings Plc | 2024-12-31 | 142.5 K |
Opthea Outstanding Bonds
Opthea issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Opthea uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Opthea bonds can be classified according to their maturity, which is the date when Opthea has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
ORACLE P 5375 Corp BondUS68389XAM74 | View | |
ORACLE P 6125 Corp BondUS68389XAH89 | View | |
ORACLE P 65 Corp BondUS68389XAE58 | View | |
ORACLE PORATION Corp BondUS68389XBU81 | View | |
ORACLE PORATION Corp BondUS68389XBT19 | View | |
ORACLE P 325 Corp BondUS68389XBN49 | View | |
ORACLE P 265 Corp BondUS68389XBM65 | View | |
ORACLE P 38 Corp BondUS68389XBP96 | View |
Opthea Corporate Filings
6K | 3rd of March 2025 A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges. | ViewVerify |
13A | 14th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Opthea Stock Analysis
When running Opthea's price analysis, check to measure Opthea's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Opthea is operating at the current time. Most of Opthea's value examination focuses on studying past and present price action to predict the probability of Opthea's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Opthea's price. Additionally, you may evaluate how the addition of Opthea to your portfolios can decrease your overall portfolio volatility.